Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT03357133

Terminated

Tirofiban for Patients Treated With Alteplase (MR TEA)

Ischemic Stroke
NCT03251963

Completed

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Surgery | Venous Thromboembolism | Deep Venous Thrombosis
NCT03893591

Completed

A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity

Obesity | Anticoagulant | Apixaban
NCT04274270

Unknown

SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer (SBRTLCES)

Radiotherapy Side Effect
NCT01732861

Completed

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Leukemia Lymphocytic Chronic B-Cell
NCT04164797

Unknown

Study of Endostar Combined With TP Regimen for Esophageal Cancer

Patients With Esophageal Cancer(Ⅱ-Ⅲ)
NCT02521714

Completed

Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension

Healthy Volunteers
NCT01972789

Completed

Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre) (FLUID)

Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD
NCT00737529

Completed

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial (EMERGE)

Mantle Cell Lymphoma
NCT00784134

Completed

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR III)

Intraventricular Hemorrhage
NCT01727843

Terminated

Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures

Femoral Neck Fracture
NCT03278262

Completed

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting (INSIGHT)

Wet Macular Degeneration
NCT02309281

Completed

Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab

Neovascular Age-related Macular Degeneration
NCT03656445

Completed

Tranexamic Acid in Total Knee Replacement

Osteo Arthritis Knee
NCT01578720

Completed

Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome

Choroidal Neovascularization | Presumed Ocular Histoplasmosis
NCT01197573

Completed

Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy

Liver Transplantation | Kidney Transplantation
NCT03533127

Unknown

A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer Recurrent
NCT02903017

Completed

Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage

Gastrointestinal Hemorrhage | Emergency Department | Tranexamic Acid | Antifibrinolytic Agents
NCT01722045

Completed

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection) (RE-VIEW)

Age - Related Macular Degeneration (AMD)
NCT02577107

Completed

Head to Head Study of Anti-VEGF Treatment. (RELIANCE)

Age-related Macular Degeneration
NCT02250118

Terminated

Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer (BEVAP)

Breast Cancer | Pleural Effusion, Malignant
NCT00722865

Terminated

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Hodgkin Lymphoma
NCT03311984

Unknown

Anti-Xa Levels in Critically Ill Patients Receiving Low-molecular-weight Heparin for Thromboprophylaxis in China

Critically Ill | Anti-Xa
NCT02302456

Completed

Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery (TRAAP)

Immediate Postpartum Hemorrhage
NCT00055237

Completed

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

HIV Infections | Kaposi's Sarcoma | HIV Seronegativity
NCT00216866

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Embolism and Thrombosis
NCT03170284

Completed

Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer (AVALANCHE)

Carcinoma, Non-Small-Cell Lung
NCT02878681

Withdrawn

24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME. (TIDE DME)

Visual Impairment Due to Diabetic Macular Edema
NCT03095079

Unknown

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

Melanoma
NCT00545792

Completed

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

Cervical Cancer | Ovarian Cancer | Endometrial Cancer | Vaginal Cancer | Carcinoma of the Vulva
NCT00901186

Completed

Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema (RED-ES)

Diabetic Macular Edema | Visual Impairment
NCT01914211

Withdrawn

The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates

Congenital Heart Disease
NCT02045030

Terminated

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
NCT01319422

Completed

Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma
NCT00967213

Completed

Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration
NCT02180204

Withdrawn

Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN) (TALISMAN)

Ischemic Stroke
NCT01777412

Completed

Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations

Neuromyelitis Optica | Neuromyelitis Optica Spectrum Disorder
NCT01724554

Completed

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion (ANDROID)

Central Retinal Vein Occlusion | Proliferative Diabetic Retinopathy
NCT00778752

Completed

Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma

Multiple Myeloma
NCT00455975

Completed

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Kidney Cancer | Renal Cancer
NCT01845844

Unknown

Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (ROTATE)

Diabetic Macular Edema
NCT02139579

Unknown

Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer

Lung, Carcinoma
NCT01314274

Completed

Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Epistaxis | HHT | Morbus Osler
NCT01368419

Unknown

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Esophageal Cancer
NCT00735813

Completed

Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia

Neoplasms | Bacteremia
NCT00661154

Completed

Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project

Colorectal Neoplasms | Rectal Cancer | Colon Cancer | Anal Cancer
NCT00111852

Completed

Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)

Stroke, Acute
NCT00467935

Completed

Scotoma Reduction in AMD Patients Treated With Ranibizumab (SALVAGE)

Macular Degeneration
NCT01327222

Completed

Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD) (LOW-VISION)

Age Related Macular Degeneration
NCT01221909

Unknown

Tranexamic Acid in Dacryocystorhinostomy (TA-DCR)

Nasolacrimal Tract Obstruction

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations